CORT vs ECL
Corcept Therapeutics Incorporated (CORT) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CORT and ECL stock pages for the full models.
Not investment advice.